NOVEMBER 2018 – A rare case of a co-located pigmented naevus and dermal cyst: The utility of very high frequency Ultrasound and Videodermoscopy for differentiation.
November 20, 2018

DECEMBER 2018 – Don’t forget about the intramuscular metastasis!

Don’t forget about the intramuscular metastasis!

Sara ffrench-Constant, Aia Mehdi, Adrian Lim
1Clinical History
A middle age female presented with back pain in 2016 with a mass in her right thigh, leg pain and fixed flexion deformity of the knee. Initial US and subsequent MRI demonstrated bilateral thigh masses which when biopsied were shown to be a high-grade malignant neoplasm with epithelial/sarcomatous elements staining positive for bHCG and AFP, but negative for smooth muscle, melanoma and lymphoma markers.

A subsequent PET-CT showed further lesions in the proximal thigh and anterior superior iliac spine as well as a 5cm posterior mediastinal mass. The overall findings were in keeping with a metastatic germ cell tumour with soft tissue metastases to the right and left thigh. The patient was treated with therapeutic radiotherapy followed by chemotherapy and initially deemed to have a good response with no measurable disease elsewhere apart from the mediastinal mass. She then re-presented in 2018 for an US Doppler of the leg owing to “calf pain” and the possibility of a deep vein thrombosis (DVT). The ultrasound findings unfortunately demonstrated a mass at the site of tenderness and was subsequently biopsied.
2Imaging findings
  • Ultrasound 2016 (Figure 1)
    • There was an abnormal soft tissue mass in the distal posterior thigh, related to the biceps femoris.
  • MRI 2016 (Figure 2)
    • Elliptical mass like lesion measuring 7.2 x 2.7cm on T1 weighted imaging which was isointense to normal muscle but demonstrates patchy, peripheral enhancement following gadolinium injection. The mass was within the short head of biceps femoris muscle.
    • Another smaller similar lesion was noted within left thigh, measuring 2.9cm lying in the fat plane between posterior thigh muscles.
  • PET/CT Sep 2016 (Figure 3)
    • FDG acid lesions seen in both thighs and within posterior mediastinum
  • MRI 2017- post chemotherapy (Figure 4)
    • Both muscle lesions showed a significant reduction in size
  • Recent Ultrasound 2018 (Figure 5)
    • There was an irregular mass in the left gastrocnemius at the site of tenderness. It was moderately vascular and was subsequently biopsied to reveal a new metastatic deposit similar to the previous lesions and thus disease progression.
3Diagnosis
Intramuscular metastatic deposit from a previous mediastinal Germ Cell Tumour
4Background
Mediastinal germ cell tumours are tumours that arise from germ cells remaining in the mediastinum during embryogenesis. They are rare; accounting for around 5-10% of mediastinal tumours [1] and are most commonly seen in young adults, with around 80% being seen in men [2]. AFP and BHCG are often expressed from these tumours and the histological characteristics are very similar to gonadal germ cell tumours.

The expression of tumour markers determines the characterisation of these tumours – either seminoma, teratoma (mature and immature) and non-seminomatous germ cell tumours (NSGCTs), with the prognosis of NSGCTs being associated with the poorest outcome [3]. Specifically, a mediastinal primary is classed as a further indicator of poor prognosis by the International Germ cell consensus classification[4]. For NSGCTs, the common therapeutic strategy is chemotherapy followed by surgery to resect the residual mediastinal tumour. Metastatic spread from NSGCTs is seen to the lung in around 10% of patients with mediastinal disease [1], with the next most common sites being liver and CNS. A number of case reports have described muscular metastases from testicular GCTs [5,6], however, there is very little in the literature describing muscular metastases from mediastinal NSGCTs at primary presentation.
5Treatment & Prognosis
Non-seminomatous mediastinal germ cell tumours are usually treated with chemotherapy (EP and POMB/ACE) and treated lesions are considered for surgical resection if they do not resolve completely. Radiotherapy may also be considered in these cases and unfortunately in our case of progressive disease through multiple treatments and resections, the patient was commenced on a trail of immunotherapy.
6Teaching Points
Non-seminomatous germ cell tumours are rare and associated with a poor prognosis Common sites of spread from mediastinal primaries are lung, liver and CNS There is very little in the literature describing their metastatic spread to muscles – however, this should be a consideration when a patient with known NSGCT presents with muscle/limb pain.
7References
[1] Mediastinal Diseases - Drew A. Torigian MD, Wallace T. Miller MD, in Radiology Secrets Plus (Third Edition), 2011, Elsevier

[2] Tumors of the Lung, Pleura, and Mediastinum - Kenneth E. Rosenzweig MD, Lee M. Krug MD, in Leibel and Phillips Textbook of Radiation Oncology (Third Edition), 2010, Saunders

[3] C. R. Nichols, “Mediastinal germ cell tumours: clinical features and biologic correlates,” Chest, vol. 99, no. 2, pp. 472–479, 1991.

[4] International Germ Cell Consensus Classification: a prognostic factor-based staging system for metastatic germ cell cancers. International Germ Cell Cancer Collaborative Group. Mead, G.M et al. J Clin Oncol. 1997 Feb; 15(2):594-603.

[5] Mixed Germ Cell Testicular Cancer with Left Ventricular Metastasis Presenting with Embolic Stroke and Small Bowel Tumor Seeding. Sundararajan S, Braunhut B, Ahmann F, Agarwal A. Case Rep Oncol Med. Vol 2014; 5 pages, article ID 250531.

[6] Metastatic Germ-Cell Cancer. Jan Menke, M.D., and Eckhardt Grabbe, M.D. July 26, 2007 N Engl J Med 2007; 357:391 DOI: 10.1056/NEJMicm060694
Translate »